Russia has announced the development of a cancer treatment vaccine, set to be distributed free of charge to patients starting in early 2025. Unlike preventive vaccines, this mRNA-based treatment is designed specifically for individuals diagnosed with cancer.
Andrey Kaprin, General Director of the Radiology Medical Research Centre, stated through Russia’s TASS news agency that pre-clinical trials have shown promising results, including tumor suppression and reduced risk of metastases. Developed under the Russian Health Ministry, the vaccine is part of the country’s advancements in cancer immunotherapy.
Russian President Vladimir Putin previously highlighted this breakthrough, noting that researchers are nearing the creation of next-generation immunomodulatory drugs and cancer vaccines. However, details regarding the types of cancer targeted or the vaccine’s official name remain undisclosed.
Globally, other nations are pursuing similar innovations. The UK has partnered with BioNTech to develop personalized cancer treatments, while Moderna and Merck & Co are advancing an experimental melanoma vaccine that has been shown to reduce recurrence or death by 50% in trials.
Alexander Gintsburg, head of the Gamaleya Center, also revealed plans to accelerate vaccine customization using artificial neural networks, reducing design time to under an hour. The global race for effective cancer treatments continues to gather momentum.